Evaluation of the Pharmacokinetics and Safety of Local Administration of EXPAREL in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Unilateral Total Knee Arthroplasty
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2015
Price : $35 *
At a glance
- Drugs Bupivacaine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pacira Pharmaceuticals
- 19 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned End Date changed from 1 Jan 2015 to 1 Mar 2015 as reported by ClinicalTrials.gov record.
- 02 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov record.